Clinical studies recruiting near Milwaukee

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Phase 1 · Froedtert & the Medical College of Wisconsin · Medical College of Wisconsin · NCT05990465 Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Medical College of Wisconsin · Arkansas Children's Hospital Research Institute · NCT03827694 Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
NA · Marquette University · Marquette University · NCT06465979 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Aurora Cancer Care-Milwaukee · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Children's Hospital of Wisconsin · National Cancer Institute (NCI) · NCT05099003 Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With
NA · Medical College of Wisconsin · Medical College of Wisconsin · NCT06048159 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Hospital of Wisconsin · National Cancer Institute (NCI) · NCT06172296 Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Phase 1 · Medical College of Wisconsin · New York Medical College · NCT04972942 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Froedtert Hospital & the Medical College of Wisconsin · Ichnos Sciences SA · NCT05862012 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Aurora Cancer Care-Milwaukee · NRG Oncology · NCT05624996 Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · Medical College of Wisconsin · Robert G. Grossman, MD · NCT00178724 Neural Mechanisms of Response Inhibition Training for OCRD
NA · UWM Anxiety Disorders Laboratory · University of Wisconsin, Milwaukee · NCT05377125 EMST in Patients Undergoing CRT for HNCA
NA · University of Wisconsin Milwaukee · University of Wisconsin, Milwaukee · NCT03916809 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Children's Hospital of Wisconsin · National Cancer Institute (NCI) · NCT05691478 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Phase 1 · Research Site · AstraZeneca · NCT06218914 A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Phase 1/Phase 2 · The Medical College of Wisconsin · ModernaTX, Inc. · NCT07116616 CUped: An Approach to Motor Recovery Post-Stroke, Not Compensation
NA · Marquette University · Marquette University · NCT06329765 The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Phase 2 · Children's Wisconsin/Medical College of Wisconsin · Children's Hospital Medical Center, Cincinnati · NCT05538208 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Medical College of Wisconsin · Eli Lilly and Company · NCT06890598 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Aurora Cancer Care-Milwaukee · PrECOG, LLC. · NCT06538038 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Medical College of Wisconsin · Children's Hospital of Philadelphia · NCT02708134 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina & Vitreous Consultants of Wisconsin · Astellas Pharma Global Development, Inc. · NCT06779773 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Columbia St. Mary's · Agendia · NCT03053193 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Hospital of Wisconsin · Children's Oncology Group · NCT04322318 MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
Phase 1 · Froedtert & the Medical College of Wisconsin · Medical College of Wisconsin · NCT04808323 Blood Flow Regulation and Neuromuscular Function Post-Stroke
NA · Medical College of Wisconsin · Medical College of Wisconsin · NCT06027294 Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leu
Phase 2 · Froedtert Hospital & the Medical College of Wisconsin · Medical College of Wisconsin · NCT04838041 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Wisconsin Center for Advanced Research · Eli Lilly and Company · NCT06937086 Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Phase 2 · Medical College of Wisconsin · New York Medical College · NCT02675959

Look up another city

Look up another condition